Just a thought - while the initial news of NOT's E2 discovery was wonderful for the stock, I am wondering if SPQ comparing to it will be useful.
Since the beginning of March, NOT has been slowly spiralling downwards, after news of the discovery. I am wondering if readers of yesterday's NR are just saying: compared to E2 is useless.
Of course, when NOT releases their assay results, it will be good for us as well, but until then, this NR will really do nothing.
IMHO, but it would be nice to be wrong.
Long and strong!